Log in to save to my catalogue

The Future of Seed Amplification Assays and Clinical Trials

The Future of Seed Amplification Assays and Clinical Trials

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2679442843

The Future of Seed Amplification Assays and Clinical Trials

About this item

Full title

The Future of Seed Amplification Assays and Clinical Trials

Author / Creator

Publisher

Lausanne: Frontiers Research Foundation

Journal title

Frontiers in aging neuroscience, 2022-06, Vol.14, p.872629

Language

English

Formats

Publication information

Publisher

Lausanne: Frontiers Research Foundation

More information

Scope and Contents

Contents

Prion-like seeded misfolding of host proteins is the leading hypothesised cause of neurodegenerative diseases. The exploitation of the mechanism in the protein misfolding cyclic amplification (PMCA) and real-time quaking-induced conversion (RT-QuIC) assays have transformed prion disease research and diagnosis and have steadily become more widely us...

Alternative Titles

Full title

The Future of Seed Amplification Assays and Clinical Trials

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2679442843

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2679442843

Other Identifiers

ISSN

1663-4365

E-ISSN

1663-4365

DOI

10.3389/fnagi.2022.872629

How to access this item